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Abstract
Changes in neuronal activity modify the structure of dendritic spines and alter the function and protein composition of
synapses. Regulated degradation of postsynaptic density (PSD) proteins by the ubiquitin-proteasome system is believed to
play an important role in activity-dependent synaptic remodeling. Stimulating neuronal activity in vitro and in vivo induces
the ubiquitination and degradation of GKAP/SAPAP and Shank, major scaffold proteins of the PSD. However, the specific
ubiquitin ligases that regulate postsynaptic protein composition have not been identified. Here we identify the RING finger-
containing protein TRIM3 as a specific E3 ubiquitin ligase for the PSD scaffold GKAP/SAPAP1. Present in PSD fractions from
rat brain, TRIM3 stimulates ubiquitination and proteasome-dependent degradation of GKAP, and induces the loss of GKAP
and associated scaffold Shank1 from postsynaptic sites. Suppression of endogenous TRIM3 by RNA interference (RNAi)
results in increased accumulation of GKAP and Shank1 at synapses, as well as enlargement of dendritic spine heads. RNAi of
TRIM3 also prevented the loss of GKAP induced by synaptic activity. Thus, TRIM3 is a novel E3 ligase that mediates activity-
dependent turnover of PSD scaffold proteins and is a negative regulator of dendritic spine morphology.
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Introduction
In mammalian neurons, excitatory synaptic transmission occurs
primarily at specialized, actin-rich protrusions called dendritic
spines. Localized to the postsynaptic membrane of spines is the
postsynaptic density (PSD), a complex protein apparatus com-
prised of glutamate receptors, associated scaffold and cytoskeletal
proteins, and signal transduction molecules. Synaptic activity
induces growth and structural rearrangements of the PSD and
dynamic turnover of PSD proteins [1,2]. Chronic alterations in
synaptic activity result in a coordinated, reversible change in
postsynaptic protein composition, with increased activity stimu-
lating degradation of a subset of PSD proteins [3]. Dendritic spines
undergo bidirectional morphological changes in response to
neuronal activity, and the morphology of individual spines is
correlated with synaptic strength and their capacity to undergo
activity-dependent plasticity [4–6]. Thus, regulated turnover of
PSD proteins may be one mechanism for determining synaptic
strength and plasticity.
The ubiquitin-proteasome system (UPS) has emerged as an
important mediator of synaptic protein degradation [7,8]. Proteins
are generally targeted for degradation by the UPS by the covalent
addition of polyubiquitin chains. Ubiquitination requires a series
of enzymatic reactions, catalyzed sequentially by E1, E2, and E3
enzymes. E3 ubiquitin ligases, hundreds of which exist in
mammalian genomes, appear to recognize specific proteins and
thus determine the specificity of protein substrates targeted for
UPS-mediated degradation [9]. While the abundance of many
proteins in the PSD is regulated by UPS activity, only a small
number of postsynaptic proteins have been observed to undergo
activity-dependent ubiquitination, including the two abundant
scaffold protein families called Shank and GKAP/SAPAP [3]. By
targeting specific substrates that serve as the structural core of the
PSD, the UPS may regulate a larger set of postsynaptic proteins.
The TRIM/RBCC proteins are a class of putative single
subunit E3 ubiquitin ligases characterized by the presence of a
tripartite motif containing a RING finger, one or two zinc-binding
B-box domains, and an associated coiled-coil domain [10,11].
This class of proteins, encoded by at least 68 genes in the human
genome, has been implicated in a variety of cellular processes and
may play a role in some human diseases. Substrates for the
ubiquitin ligase activity of a number of TRIM proteins have been
identified [10]; for example, TRIM18/Mid2, implicated as the
cause of X-linked Opitz syndrome, degrades protein phosphatase
2A [12]. The TRIM family member TRIM3 was originally
identified as a brain-enriched RING finger protein (BERP) [13]. It
is highly expressed in brain, and is reported to interact with
myosin Vb and the actin-binding protein a-actinin-4 [13,14].
However, the E3 ligase activity of TRIM3 has not been established
and its substrates are unknown.
The GKAP (also known as SAPAP) and Shank family of
proteins are abundant interacting scaffolds of the PSD [2,15]. By
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PSD-95 protein complex, including NMDA-type glutamate
receptors [16,17] GKAP and Shank protein levels in synapses
are regulated by activity and they are among the most prominently
ubiquitinated proteins in the PSD [3]. In this study, we identify
TRIM3 as a specific E3 ligase for GKAP. TRIM3 induces
ubiquitination and proteasome-dependent degradation of GKAP
in heterologous cells. Overexpression of TRIM3 in hippocampal
neurons suppresses GKAP protein levels, concomitant with loss of
Shank1 and reduced spine head width. Conversely, RNAi
knockdown of TRIM3 resulted in an accumulation of postsynaptic
GKAP and Shank and spine head enlargement. We also present
evidence that TRIM3 is involved in the activity-dependent
turnover of GKAP. These results identify a novel ubiquitin ligase
involved in regulation of PSD composition and dendritic spine
morphology.
Results
Identification of TRIM3 as a putative postsynaptic
regulator by RNAi screen
To identify specific E3 ligases that mediate degradation of PSD
proteins, we performed an RNAi screen of a subset of known and
putative E3 enzymes in primary hippocampal neurons. The initial
screen targeted cullins 1, 2, 3, 4A and 5, core subunits of a
superfamily of multisubunit ubiquitin ligases [18]; APC2, a cullin-
related subunit of the anaphase-promoting complex [19]; E6-AP
(also known as Ube3A), a single subunit E3 whose mutation
underlies a human mental retardation syndrome called Angelman
syndrome [20]; and Mdm2, an E3 that was reported to
ubiquitinate PSD-95 [21]. In addition, we included two members
of the TRIM/RBCC family of putative RING finger E3 ligases --
TRIM3 and TRIM9 -- that have been detected in the PSD by
mass spectrometry [22]. Three different shRNAs were designed
against each candidate E3 (except APC2, which had two shRNAs)
and expressed from the plasmid vector pSUPER [23].
If a specific E3 mediates the ubiquitination and degradation of a
PSD protein, then that PSD protein should accumulate to higher
levels when expression of the endogenous E3 is suppressed by
RNAi. For the initial screen, we transfected pools of RNAi
constructs targeting individual E3 candidates together with a
‘‘reporter’’ PSD protein construct -- GFP-tagged Shank1A, a full-
length splice variant of Shank1 [16,24]. In addition to being itself a
target of UPS degradation [3], Shank1A is localized to synapses,
and its accumulation requires other scaffold proteins in the PSD,
including GKAP, Homer, and PSD-95 [16,17,25]. Screening with
the GFP-tagged reporter offers a technical advantage over
endogenous Shank1 staining because the GFP fluorescence
necessarily stems from the neuron transfected with the RNAi
constructs and reduces experimental variability introduced by
immunostaining. Thus, we reasoned that an increase of GFP-
Shank1A at postsynaptic sites would reflect impaired degradation
of Shank1A itself or of other proteins controlling the size of the
PSD. Cultured rat hippocampal neurons were transfected at 14
days in vitro (DIV 14) with GFP-Shank1A and pools of RNAi
constructs targeted against each individual E3. After three days,
GFP-Shank1A fluorescence intensity was measured in transfected
cells in ‘‘blinded’’ fashion.
Intransfectedneurons, GFP-Shank1Aaccumulatedina punctate
spiny distribution along dendrites consistent with a postsynaptic
localization (Figure 1A), and as previously reported [26]. The
majority of pooled RNAi constructs had no effect on the pattern
or fluorescence intensity levels of the GFP-Shank1A reporter.
However,cotransfectionwith thepooledTRIM3 shRNAconstructs
led to a highly significant increase in GFP-Shank1A fluorescence
(Figure 1A, B). APC2 knockdown also had a similar, albeit less
robust, effect. With RNAi pools targetingE6-AP/Ube3A orMdm2,
onlyasmallnumberoftransfectedneuronscould beidentified,all of
which appeared unhealthy; thus, these were excluded from further
analysis (data not shown).
To corroborate the TRIM3 result, we next tested the three
TRIM3 shRNA plasmids separately. Neurons transfected with
each of the individual TRIM3 shRNA plasmids showed increased
GFP-Shank1A fluorescence; the biggest effect was seen with
construct TRIM3/264. (Figure 1C, D). GFP-PSD-95 also targets
to postsynaptic sites when transfected into hippocampal neurons
(Figure 1C). However, in contrast to their effect on GFP-Shank1A,
none of the TRIM3 RNAi plasmids affected the pattern or
intensity of overexpressed GFP-PSD-95. The fact that TRIM3
knockdown shows some selectivity in its effect on postsynaptic
scaffold proteins, and that it increases postsynaptic accumulation of
GFP-Shank1A, would argue against a non-specific toxic effect of
TRIM3 RNAi in neurons.
Using an antibody against the N-terminal domain of TRIM3
that does not cross-react with TRIM9 or the highly homologous
TRIM2 protein (Figure S1A), we examined the effects of TRIM3
RNAi on the expression of TRIM3 in cultured hippocampal
neurons. Each of the TRIM3 RNAi constructs reduced the
immunostaining of endogenous TRIM3 in both cell body and
dendrites of transfected cells (Figure S1B). The knockdown of
TRIM3 expression by the TRIM3/2756 shRNA (which is
directed against the 39 untranslated region) could be rescued by
overexpression of wildtype TRIM3 lacking its native 39 UTR.
RNAi constructs targeting TRIM2 or zinc transporter ZnT3 did
not affect TRIM3 staining in neurons. As expected, the TRIM3/
264 RNAi construct also decreased the expression of cotransfected
TRIM3 protein in COS7 cells, while having no effect on the
related protein TRIM2 (Figure S1C).
Expression and distribution of TRIM3 in brain and
cultured neurons
What is the expression pattern of TRIM3 in neurons? Previous
studies showed that TRIM3 mRNA expression is highest in the
brain, moderate in the lung and low in liver, kidney, and heart
[13]. By immunoblotting, TRIM3 was expressed in the brain at
low levels at embryonic day 15 (E15) and then increased during
the first two postnatal weeks before decreasing through adulthood
(Figure 2A, B). The pattern differed from the steeply rising
expression of PSD-95 and GKAP during postnatal development
(Figure 2A, B). Two major bands were detected in TRIM3
Western blots of brain tissue (Figure 2A), with the higher band
corresponding to the predicted ,81 kDa molecular weight for the
full-length protein. As both bands were similarly detected when
the full-length TRIM3 cDNA was overexpressed in COS-7 cells
(Figure S1A), the lower band is more likely to be a cleavage
product of TRIM3 rather than an alternative spliced form or
related protein.
Subcellular fractionation of rat forebrain showed TRIM3 to be
particularly abundant in the light membrane fraction (P3), and
sparse in the cytosol (S3) (Figure 2C). TRIM3 was also present in
the Triton X-100-resistant PSD fractions (PSDI and PSD II),
which corroborates its detection in the PSD by mass spectrometry
[22]. However, TRIM3 is not enriched in the PSD like PSD-95
and is extracted by Sarkosyl detergent (PSDIII), indicating that
TRIM3 is not tightly associated with the PSD (Figure 2B).
By immunostaining, TRIM3 was widely distributed in a
micropunctate pattern throughout the cell body, axon, and
dendrites of cultured hippocampal neurons (Figure 2C), consistent
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staining was diminished specifically with TRIM3 RNAi constructs
and not by other shRNAs, confirming the specificity of the
antibody staining (see Figure S1B). Unlike GKAP or PSD-95,
TRIM3 was not concentrated in synaptic clusters. It was also
undetectable in glial cells in our cultures (data not shown).
Increased neuronal activity has been reported to upregulate
TRIM3 mRNA levels in the brain [27]. To examine whether
TRIM3 protein levels in primary hippocampal neurons were
altered by changes in activity, we treated cultures with either
bicuculline (50 mM) or tetrodotoxin (TTX; 3 mM). We did not
detect any significant change in TRIM3 expression with treatment
times varying from 2 to 24 hours (Figure S2A). Furthermore,
chronic treatment (24 h) did not affect the distribution of TRIM3
in dissociated neurons, with no change in the diffuse staining
pattern (Figure S2B).
TRIM3 is an E3 ligase for GKAP
The TRIM3 RNAi phenotype implies that TRIM3 normally
functions to suppress the postsynaptic levels of Shank1 protein in
neurons. Assuming that TRIM3 is an E3 ligase, its effect could be
mediated directly by ubiquitination/degradation of Shank1, or
indirectly by degradation of another protein that influences Shank
accumulation in spines. We therefore tested in heterologous cells
whether overexpression of TRIM3 can stimulate the degradation
of Shank1A or GKAP/SAPAP1, another abundant PSD scaffold
that is implicated in Shank1 accumulation in the PSD [16,17].
Overexpression of TRIM3 in COS7 cells reduced the protein
levels of cotransfected HA-tagged Shank1A (Figure 3A, second
row; quantified in B). Remarkably, TRIM3 had an even more
robust effect on GKAP/SAPAP1, strongly suppressing protein
expression (Figure 3A, top row). In contrast, TRIM3 had no effect
on expression of PSD-95 or Shank2, a close relative of Shank1.
Overexpression of TRIM9 (another neuronal TRIM protein) or
Mdm2, two other single subunit E3 ligases, did not inhibit
Shank1A or GKAP expression in heterologous cells. In fact,
TRIM9 overexpression robustly increased protein levels of HA-
GKAP, HA-Shank1A and Myc-PSD-95 (Figure 3A, B), possibly
by sequestering other components required for protein degrada-
tion. Thus, in heterologous cells, TRIM3 specifically suppresses
Figure 1. RNA interference-based screen for E3 ubiquitin ligases regulating GFP-Shank1A expression. (A) Primary rat hippocampal
neurons (DIV 14)were cotransfected with GFP-taggedShank1Aandeitheremptyvector(pSUPER) or poolsofRNAi plasmids targetingvarious E3ligases,
as indicated. Images show GFP-Shank1A fluorescence. High magnification panels show representative dendritic segments. (B) Quantification of GFP-
Shank1A fluorescence in transfected neurons, normalized to signal in pSUPER-transfected cells within the same experiment. Histograms (mean 6 SEM)
show average GFP intensity for cells from 3–4 independent experiments. (C) Effect of different individual TRIM3 RNAi constructs on expression of
cotransfected GFP-Shank1A or GFP-PSD-95. (D) Quantification of GFP-Shank1A or GFP-PSD-95 signal from neurons cotransfected with individual TRIM3
RNAi plasmids, normalized to pSUPER vector control. p-values are calculated relative to pSUPER control. *p,0.05, ***p,0.001, ****p,0.0001, t-test.
doi:10.1371/journal.pone.0009842.g001
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directly interact with each other.
In addition to the defining motifs of TRIM proteins (RING
finger, B-Box, and coiled coil), TRIM3 contains a series of six NHL
repeats (first identified in NCL-1, HT2A, and LIN-41) [28] (see
Figure 3C). These repeats are similar to WD repeats, which are
known to be involved in protein-protein interaction and are the
substrate-recruiting module of many E3 ligases [29]. To determine
which regions of TRIM3 are required for the suppression of
Shank1A and GKAP, we examined the effects of several deletion
mutants lacking variousdomainsof TRIM3(Figure3C).Allofthese
mutant constructs lost the ability to reduce GKAP expression in
COS7 cells (Figure 3D). From this experiment,we conclude that the
RING finger domain and the C-terminal half of TRIM3 containing
the NHL repeats are both required for TRIM3 to suppress GKAP
protein levels. Because the RING finger domain plays a critical role
in E3 ligase function by mediating the transfer of ubiquitin to target
substrates [30], our data are consistent with TRIM3 acting as an E3
ubiquitinating enzyme for GKAP.
RING finger structure and function requires zinc coordination by
conserved cysteine and/or histidine residues [30]. Mutation of the
first two conserved cysteine residues (C22S/C25S) abolished the
ability of TRIM3 to suppress GKAP protein levels (Figure 3E). In
fact, GKAP expression was increased by coexpression of C22S/
C25S-TRIM3 compared to the negative control (empty vector),
suggesting a dominant negative effect of this mutant. In addition, the
loss of GKAP with TRIM3 cotransfection was blocked by addition of
the proteasome inhibitors MG-132 or lactacystin (Figure 3F). These
data strongly support the idea that TRIM3 suppresses GKAP protein
expression by stimulating UPS-mediated degradation of GKAP.
Surprisingly, the TRIM3 deletion constructs DRING, DRBCC,
and RING still resulted in loss of Shank1A protein in COS-7 cells,
eventhoughthesemutantsshouldbedefectiveasE3ligasesandwere
incapable of suppressing GKAP protein expression (Figure 3D). In
addition, proteasomal inhibition by MG-132 did not fully prevent
the decrease in Shank1A induced by cotransfection of TRIM3 (data
not shown). At least in heterologous cells, therefore, the inhibition of
Shank1A proteinlevels byTRIM3appears to be unrelated to the E3
Figure 2. Expression and distribution of TRIM3 in cortex and cultured neurons. (A) Developmental expression of TRIM3. Total
homogenates were prepared from rat forebrain at various ages. Equal amounts of protein were immunoblotted for TRIM3, PSD-95 or GKAP. (B)
Immunoblots were quantified by densitometry in triplicate or quadruplicate. Signals were normalized to peak expression level. For TRIM3 and GKAP,
the plotted signal represents the sum of multiple protein bands. Mean 6 SEM is shown. (C) Biochemical fractionation of adult rat cerebral cortex.
Protein amounts loaded were 30 mg/lane (TRIM3) or 10 mg/lane (PSD-95) for S2, P2, S3, P3, and synaptosomes, and 7.5 mg/lane (TRIM3) or 2.5 mg/lane
(PSD-95) for PSDI, -II, -III samples. (D) Cultured rat hippocampal neurons (DIV 19) were immunostained for TRIM3 (green), GKAP (red) and PSD-95
(blue). High magnification panels show representative dendritic and axon segments.
doi:10.1371/journal.pone.0009842.g002
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more likely than Shank1A to be a conventional substrate of TRIM3-
mediated UPS degradation.
If TRIM3 is a genuine E3 for GKAP, it should be able to
stimulate ubiquitination of GKAP. We cotransfected COS7 cells
with FLAG-GKAP, Myc-tagged ubiquitin, and either wildtype
Figure 3. TRIM3 is a ubiquitin ligase for GKAP. (A) COS-7 cells were cotransfected with a plasmid expressing an epitope-tagged target protein
(either GKAP, Shank1A, Shank2, or PSD-95) and either an empty vector (Control) or a FLAG-tagged E3 ligase (rat TRIM3, TRIM9, or human Mdm2). Cell
lysates were immunoblotted for FLAG (representative example shown in bottom panel), and for the coexpressed target protein, as indicated. (B)
Immunoblots were quantified by densitometry, and signals were normalized to the empty FLAG vector control. Histograms show means 6 SEM for
3–6 experiments each. p-values are calculated relative to FLAG control. *p,0.05, ***p,0.001, ****p,0.0001, Student t-test. (C) Schematic diagram of
TRIM3 deletion constructs, showing RING, B-box, coiled coil (CC), and NHL repeat domains. The gray oval denotes a mutated RING domain with
cysteine to serine substitutions at amino acid positions 22 and 25. FLAG epitope tags are located at the amino terminus. (D) Effect of TRIM3 deletion
mutants on GKAP and Shank1A expression in COS-7 cells. The lower panel shows the expression of the FLAG-tagged TRIM3 mutants, each at the
expected molecular weight. (E) HA-GKAP was cotransfected with either wildtype TRIM3, or the C22S/C25S mutant TRIM3. All tested mutations abolish
TRIM3-mediated GKAP degradation. Western blot of a-tubulin is shown as a loading control. (F) COS-7 cells were cotransfected with HA-GKAP and
either empty FLAG vector (2) or FLAG-TRIM3 (+). Prior to harvesting, cells were left untreated or were treated either with 20 mM MG-132 or 5 mM
lactacystin for 14 hours. Cell lysates were immunoblotted with either FLAG or HA antibody, with a-tubulin loading control. (G) Ubiquitination of GKAP
stimulated by coexpression of wildtype, but not mutant, TRIM3. HEK293 cells were cotransfected with FLAG-GKAP, Myc-tagged ubiquitin, and either
empty vector, wildtype HA-TRIM3, or the C22S/C25S mutant, as indicated. Cells were treated with MG-132 for 14 hours prior to harvesting to block
proteasome-dependent GKAP degradation. Cell lysates were prepared under denaturing conditions, immunoprecipitated with FLAG antibody-
coupled Sepharose, and immunoblotted as shown. As a negative control, no myc-ubiquitin signal is immunoprecipitated in the absence of FLAG-
GKAP (first three lanes).
doi:10.1371/journal.pone.0009842.g003
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treated with MG-132 to prevent substrate degradation, and
GKAP was immunoprecipitated with FLAG antibodies and
immunoblotted for Myc-ubiquitin. In cells expressing wildtype
TRIM3, there was a marked increase in the amount of myc-
ubiquitinated GKAP, compared to cells lacking TRIM3 or
expressing the C22S/C25S mutant. In the absence of FLAG-
GKAP, no Myc signal was immunoprecipitated by the FLAG
antibody, indicating that the Myc-ubiquitin is specifically associ-
ated with GKAP, rather than non-specifically immunoprecipitat-
ed. Collectively, these data suggest that TRIM3 stimulates GKAP
degradation by acting as a specific ubiquitin ligase for GKAP.
TRIM3 regulates GKAP and Shank1 expression in
hippocampal neurons
We next examined whether TRIM3 functions in neurons to
regulate expression of endogenous GKAP protein. Cultured
hippocampal neurons were cotransfected at DIV 14 with a b-
galactosidase marker and TRIM3 constructs, and immunostained
four days later for endogenous GKAP. In neurons overexpressing
TRIM3, levels of dendritic GKAP were significantly reduced
(Figure 4A, quantified in C). Conversely, RNAi knockdown of
TRIM3 (TRIM3/264 RNAi) resulted in increased GKAP
immunoreactivity. The intensity of endogenous Shank1 immuno-
staining also showed bidirectional changes with TRIM3 overex-
pression and TRIM3 RNAi, similar to GKAP (Figure 4B, C). The
increase of endogenous Shank1 with TRIM3 knockdown is in
keeping with the effect on exogenous GFP-Shank1A in the original
RNAi screen (see Figure 1). These gain- and loss-of-function data
show that TRIM3 modulates the postsynaptic levels of GKAP and
Shank1 scaffolds endogenously in neurons.
The abundance of GKAP in the PSD is regulated bidirectionally
over many hours by neuronal activity [3]. In cultured hippocampal
neurons transfected with b-gal alone, suppressing activity with
tetrodotoxin (TTX, 3 mM, 24 h) resulted in higher levels of GKAP
staining in dendrites, whereas stimulating activity with bicuculline
(50 mM, 24 h) reduced GKAP protein expression (Figure 4D,
quantified in E). Similar results were obtained in neurons transfected
with a control RNAi constructtargeting ZnT3, a zinc transporter. In
cells overexpressing wildtype TRIM3, endogenous GKAP staining
was depleted and treatment with bicuculline had no additional
lowering effect. Thus, TRIM3 overexpression ‘‘occluded’’ the effect
of hyperactivity on GKAP levels. Although TRIM3 overexpression
by itself inhibited GKAP protein expression, it did not prevent an
increase of GKAP expression induced by TTX. This latter result
suggeststhatTRIM3functionmaybeitselfunderactivity-dependent
control, or there are alternate ways to increase GKAP expression
that are independent of TRIM3.
In neurons expressing TRIM3/264 shRNA, bicuculline treat-
ment failed to lower GKAP protein expression, despite a higher
‘‘baseline’’ level of GKAP (Figure 4D, E). Conversely, TRIM3
RNAi had no additional effect on elevation of GKAP expression
by TTX. The simplest interpretation of these results is that
TRIM3 is required for activity-induced downregulation of GKAP,
and loss of TRIM3 occludes the upregulation of GKAP by chronic
hypoactivity (TTX). Overall, we conclude that endogenous
TRIM3 is important for activity-dependent regulation of postsyn-
aptic GKAP levels.
TRIM3 modulates dendritic spine morphology
PSD scaffold proteins are known to regulate dendritic spine
morphology [6,25,31]. We therefore asked whether TRIM3, as an
E3 ligase, has any role in regulating dendritic spine morphogen-
esis. Dissociated hippocampal neurons (DIV14) were transfected
for 3 days with b-galactosidase (to visualize spine morphology)
and either wildtype TRIM3 or mutants DRING or C22S/C25S.
Compared with vector-transfected cells, neurons overexpressing
wildtype TRIM3 showed a decrease in spine head width, while
those overexpressing the putative dominant negative TRIM3
mutants had enlarged spine heads (Figure 5A, B) There was little
effect on spine length (Figure S3A) or spine density (spines/10 mm
6 SEM; Control: 4.7960.18; TRIM3 4.8860.22; DRING
5.3660.29; C22S/C25S 4.8760.21). We noted that deletion or
mutation of the RING finger domain altered the distribution of
the overexpressed protein (Figure 5A). Whereas the overexpressed
wildtype protein was present diffusely within the cell including
dendritic spines, the mutant TRIM3 proteins showed a ‘‘fibrillar’’
pattern in the dendrite shaft and were excluded from spines.
To corroborate the dominant negative experiments, we
analyzed the effects on spine morphology of two different TRIM3
RNAi constructs (TRIM3/264, directed against part of the coding
sequence, and TRIM3/2756, targeted against the 39 untranslated
region). Similar to the RING finger mutants, both TRIM3 RNAi
plasmids induced a significant increase in dendritic spine head
width (Figure 5C, D). When FLAG-tagged TRIM3 was
coexpressed with TRIM3/2756 shRNA (FLAG-TRIM3 plasmid
does not contain the 39 UTR, and is therefore insensitive to
knockdown by TRIM3/2756 RNAi), the phenotype shifted back
toward thinner spines. This ‘‘rescue’’ experiment suggests that the
enlargement of spine heads is a specific consequence of TRIM3
knockdown, and not an off-target effect of the shRNA. RNAi
knockdown of TRIM3 did not greatly influence spine length
(Figure S3B) or density (spines/10 mm; pSUPER: 5.3460.18;
TRIM3/264 6.1860.24; TRIM3/2756 5.0260.29; TRIM3/
2756 = wt TRIM3 4.5260.18). Taken together, our findings
imply that TRIM3 functions normally to inhibit growth of
dendritic spine heads, dependent on its ubiquitin ligase activity.
Discussion
Many proteins of the PSD are dynamically regulated by
translocation to and from the synapse and by degradation [1,2]. A
subset of these PSD proteins show coordinated bidirectional
changes in abundance in response to chronically altered activity
mediated by the UPS [3]. However, the E3 ligases that govern
activity-dependent turnover of specific PSD components have not
been identified. In this study, we identify TRIM3 as an E3 ligase
that selectively targets GKAP, based on the following evidence. (i)
TRIM3 stimulates the ubiquitination and loss of GKAP in
heterologous cells, dependent on the RING finger of TRIM3 and
on proteasome function; (ii) overexpression of TRIM3 leads to the
depletion of endogenous GKAP in neurons; (iii) RNAi knockdown
of endogenous TRIM3 in neurons results in elevated levels of
postsynaptic GKAP. The presence of TRIM3 in PSD fractions
(initially discovered by unbiased proteomic approaches [22]) lends
further support to the idea that TRIM3 has a role at postsynaptic
sites.
RNAi knockdown of TRIM3 also resulted in increased
abundance of Shank at postsynaptic sites, which is in keeping
with the original RNAi screen that identified TRIM3 and which
used GFP-Shank1 as the ‘‘reporter’’. This fact notwithstanding,
our data are more consistent with the idea that GKAP is the direct
target of TRIM3 and that the effect of TRIM3 on Shank1
expression occurs secondarily to GKAP loss. Although TRIM3
suppressed protein levels of Shank1 in heterologous cells, this effect
was surprisingly not dependent on the presence of the RING
finger domain and was not completely blocked by proteasome
inhibitors, in contrast to suppression of GKAP by TRIM3. Thus,
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TRIM3. It is known that Shank proteins bind directly to GKAP
through an interaction between the Shank PDZ domain and the
C-terminus of GKAP. In neurons, disrupting this interaction
results in the loss of Shank from synapses and accumulation of
Shank within the cell body [16,17]. Thus, the parallel changes in
Shank1 upon manipulation of TRIM3 could be explained by
decreased stabilization of Shank at the PSD secondary to GKAP
loss.
Based on its interaction with myosin Vb, TRIM3 has been
proposed to be involved in organelle or vesicle transport [13,32]. It
is intriguing that GKAP itself can associate with myosin V via its
dynein light chain subunit [33]. Myosin V could thus bring together
TRIM3 and its substrate GKAP, or mediate the cotrafficking of
Figure 4. TRIM3 modulates basal and activity-regulated GKAP levels in hippocampal neurons. (A) Rat hippocampal neurons were
transfected at DIV14 with b-galactosidase (b-gal) and either empty vector, wildtype TRIM3, or TRIM3/264 RNAi plasmid. After four days, cells were
double-labeled for GKAP (green) and either b-gal or the overexpressed TRIM3 protein (red). Representative neurons are shown, with higher
magnification images of dendritic segments. The bottom row shows the GKAP (green) channel in grayscale. (B) Similar experiment to (A), with cells
double-labeled for Shank1 (green) and either b-gal or the overexpressed TRIM3 protein (red). (C) Quantification of endogenous GKAP or Shank1
immunofluorescence upon TRIM3 overexpression (TRIM3 ox) or knockdown with TRIM3/264 RNAi. Intensity is normalized to cells transfected with
empty vector. (D) Neurons were transfected at DIV14 with b-galactosidase (b-gal) and either empty vector, wildtype TRIM3, TRIM3 RNAi plasmid, or an
unrelated RNAi (ZnT3). After three days, cells were treated for an additional 24 hours with either TTX (3 mM) or bicuculline (50 mM) prior to staining. (E)
Quantification of endogenous GKAP immunofluorescence intensity upon TRIM3 overexpression or knockdown, in untreated neurons or after TTX or
bicuculline treatment. The data used for untreated cells is the same as that shown in (C), replotted here for comparison with TTX and bicuculline
treated conditions. Histograms show mean 6 SEM for a minimum of 13 neurons per condition. *p,0.05, **p,0.01, ***p,0.001; ****p,0.0001, t-test.
doi:10.1371/journal.pone.0009842.g004
Postsynaptic Function of TRIM3
PLoS ONE | www.plosone.org 7 March 2010 | Volume 5 | Issue 3 | e9842Postsynaptic Function of TRIM3
PLoS ONE | www.plosone.org 8 March 2010 | Volume 5 | Issue 3 | e9842these proteins. Our biochemical data suggest that TRIM3 plays a
directroleinUPS-mediatedGKAP loss, butwe cannot exclude that
TRIM3 also regulates the trafficking of GKAP to and from
synapses.
In neurons, chronic enhancement of synaptic activity with
bicuculline treatment increases the level of ubiquitinated GKAP [3]
and leads to depletion of synaptic GKAP in a TRIM3-dependent
manner (this study). The increased ubiquitination and turnover of
GKAP by activity implies that the target protein (GKAP) and/or
the UPS system must be modified by neuronal excitation. Elevated
activity could potentially induce phosphorylation of GKAP,
marking it for destruction. Phosphorylation-dependent recruitment
of E3 ligases to substrates is a well-established means of regulating
ubiquitination of specific substrates [34]. It is noteworthy that
TRIM3 contains C-terminal NHL repeats, a protein motif that
resembles the WD repeats found in many F-box proteins, the
substrate recognition component of multisubunit SCF (Skp-1/
cullin/F-box) E3 ligases. WD repeats can specifically recognize
phosphorylated substrates for UPS-mediated degradation [35–37].
Synaptic activity stimulates a number of protein kinases, which
could potentially mark GKAP for degradation. The identity
of such a kinase and the site of phosphorylation remain to be
investigated.
Alternatively, activity could affect the expression, function or
subcellular localization of TRIM3, thereby stimulating GKAP
ubiquitination-degradation. Indeed, increased activity stimulates
TRIM3 mRNA expression in the brain [27]. However, we
observed no major changes in TRIM3 protein expression or
localization in dissociated hippocampal cultures in response to
chronic TTX or bicuculline. In addition, neuronal activity
promotes translocation of proteasomes into dendritic spines,
thereby delivering the protein degradation machinery to its
intended synaptic targets [38]. One of our findings suggesting
activity-dependent regulation of TRIM3 function is that TRIM3
RNAi increases dendritic GKAP levels under conditions of basal
(control) or increased synaptic activity (bicuculline), but has no
significant effect when neurons are silenced by TTX (see Figure 4).
One possible explanation is that TRIM3 enzymatic function is
stimulated by activity and inactivated in the presence of chronic
TTX.
We also show here that TRIM3 negatively regulates the size of
spine heads, with loss of function resulting in increased spine size.
The morphological changes are presumably a postsynaptic effect,
as they are observed in the spines of transfected cells in which
TRIM3 expression has been altered. The mechanism likely
involves the direct or indirect loss of PSD scaffold proteins such
as GKAP and Shank, as Shank1 strongly promotes spine head
enlargement [25]. Regulation of excitatory synapses may depend
on a complex balance between opposing sets of E3 ligases, as
different E3s have been reported to either increase or decrease
synaptic size [39,40]. TRIM3 is likely to have additional
postsynaptic substrates, and based on its presence in axons, may
also have a presynaptic role.
Recent studies have demonstrated that dendritic spine dimensions
are bidirectionally regulated by synaptic activity, and that synaptic
transmission and calcium signaling is determined by the shape of
individual spines [41]. Thus, E3 ligases such as TRIM3 that regulate
postsynapticGKAPand Shankcontent couldplayimportantrolesin
synaptic function and plasticity. Interestingly, a recent study
demonstrates that GKAP and Shank are polyubiquitinated after
retrieval of contextual fear memory [42]. Furthermore, mutations in
members of the GKAP/SAPAP and Shank family of genes may
contribute to obsessive-compulsive and autism spectrum disorders,
respectively [43–45], indicating that proper regulation of the
turnover of these proteins is critical for normal cognitive functions.
Methods
RNA interference screen
Two to three annealed sets of oligonucleotides encoding small
hairpin RNAs targeting unique sequences for each E3 ligase
component (see Table S1) were cloned individually into pSUPER
[23]. The GFP-Shank1A reporter construct contained the entire rat
Shank1A coding region and 523 bp of the 39 untranslated region
shown to mediate dendritic targeting of the transcript [46], under
the control of the ubiquitin promoter. The GFP-Shank1A plasmid
was cotransfected into primary rat hippocampal neurons (DIV 14)
withpools of RNAi plasmids at a DNA mass ratio of 1:3. After three
days, cultures were fixed with 4% paraformaldehyde/4% sucrose,
and GFP fluorescence was imaged directly by confocal microscopy.
GFP-Shank1A signal was measured by integrating GFP fluores-
cence intensity and normalizing to cells transfected with pSUPER
control. The mean number of cells analyzed per target (n) was 44
(range 25–69), taken from 3–4 independent experiments. The PSD-
95-GFP construct has been described previously [47].
DNA constructs
The following mammalian expression plasmids have been
described: pGW1/HA-GKAP [48], pGW1/HA-Shank1A [25],
pGW1/Myc-PSD-95 [49]. COS-7 cell experiments were performed
using a construct encoding the full-length short form of GKAP/
SAPAP1[48].Full-lengthratTRIM3,TRIM2,andTRIM9cDNAs
were isolated by PCR from a rat brain cDNA library, cloned into a
modified pGW1 vector (British Biotechnology) containing an N-
terminal FLAG epitope, and confirmed by direct sequencing.
Deletion mutants of TRIM3 were generated by PCR, and the
C22S/C25S mutant was generated by site-directed mutagenesis
using the QuikChange method (Stratagene). To generate doxycy-
cline-inducible TRIM3 and TRIM2 expression constructs, full-
length cDNAs were cloned into a modified pTRE vector (Clontech).
Antibodies and biochemistry
Rabbit GKAP (C9589) and guinea pig PSD-95 antibodies have
been described previously [48,50]. The GKAP antibody was
generated against the conserved C-terminus and recognizes all
isoforms.MousePSD-95(clone K28/43)wasagiftfromJ.Trimmer
Figure 5. Regulation of dendritic spine morphology by TRIM3. (A) Cultured hippocampal neurons were cotransfected at DIV14 for three days
with either empty FLAG vector (Control), FLAG-TRIM3 (wildtype), or TRIM3 mutants defective in RING finger function (DRING or C22S/C25S) along
with b-galactosidase (b-gal) to visualize cell morphology. Cells were double-labeled for the FLAG-tagged protein and b-gal. Representative
transfected neurons are shown, with higher magnification images of dendritic segments (labeled for b-gal). (B) Quantification of spine head width
upon overexpression of wildtype or mutant TRIM3. Cumulative frequency distribution is shown at right. (C) Effect of TRIM3 knockdown by RNAi on
dendritic spines. DIV14 hippocampal neurons cotransfected with b-gal and either pSUPER, TRIM3/264 or TRIM3/2756 RNAi constructs are shown, with
representative dendritic segments. The effect of TRIM3/2756 is negated by the overexpression of wildtype TRIM3. (D) Quantification of spine head
width from cells transfected as in (C), with cumulative frequency distribution shown at right. Spines from at least 13–14 cells (overexpression) or 24
cells (RNAi) were quantified. *p,0.05, ***p,0.001, ****p,0.0001, t-test. Each cumulative frequency distribution of spine head width (B and D) is
significantly different from control (p,0.0001, Kolmogorov-Smirnov test).
doi:10.1371/journal.pone.0009842.g005
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mercial sources: mouse anti-BERP/TRIM3 (BD Biosciences);
rabbit anti-Shank1A (Chemicon); rabbit (ICN), mouse (Promega)
anti-b-galactosidase; rabbit anti-HA, mouse anti-myc (Santa Cruz);
rabbit and mouse anti-FLAG (Sigma); Alexa488-, Alexa568-
conjugated secondary antibodies (Molecular Probes). Tetrodotoxin,
bicuculline, and MG-132 were obtained from Sigma.
Biochemical fractionation of rat forebrain was performed as
described previously [51]. COS-7 cells were transfected using
Lipofectamine (Invitrogen). For immunoprecipitation, cells were
extracted with buffer A (50 mM Tris, ph 7.4, 150 mM NaCl,
5 mM EDTA, 5 mM EGTA, protease inhibitors) containing 2%
SDS at 4uC. for 1 hr. After centrifugation at 16,000 g for 30
minutes, extracts were diluted with 9 volumes of buffer A
containing 1% Triton, and then immunoprecipitated with FLAG
M2-agarose (Sigma).
Primary hippocampal neuron culture, transfection and
immunocytochemistry
Primary hippocampal neuron cultures were prepared from
embryonic day 19 (E19) rat hippocampi, and plated onto glass
coverslips coated with poly-D-lysine (30 mg/ml) and laminin
(2 mg/ml) at a concentration of 150–200 cells/mm
2, as described
previously [52]. Cultured neurons were transfected on DIV14
using Lipofectamine 2000 (Invitrogen). For spine experiments, b-
galactosidase and RNAi plasmids were cotransfected at a ratio of
1:3. In rescue experiments with wildtype TRIM3, ratio of b-
galactosidase:FLAG-TRIM3:RNAi plasmids was 1:1:3. Tetrodo-
toxin (3 mM) or bicuculline (50 mM) was added three days after
transfection, and cells were incubated for an additional 24 hr.
For immunocytochemistry, neurons were fixed with 4%
paraformaldehyde (PFA)/4% sucrose for analysis of cell morphol-
ogy, or briefly with 4% PFA followed by methanol (220uC) for
immunofluorescent labeling of synaptic proteins. Primary and
secondary antibodies were applied in GDB buffer (30 mM
phosphate buffer, pH 7.4, containing 0.2% gelatin, 0.45 M NaCl,
0.5% Triton X-100).
Image analysis and quantification
Confocal images of transfected neurons were obtained with a
LSM510 confocal microscope (Zeiss) using a Zeiss 63x (N.A. 1.4)
oil objective with sequential acquisition settings of 102461024
pixels. Each image was a z-series projection of 6–10 images, each
averaged 2 times and taken at 0.36 mm depth intervals. When
fluorescence intensity was compared, confocal settings were kept
unchanged within a given experiment. Fluorescence quantification
and morphometric analysis were performed using MetaMorph
software (Universal Imaging). Fluorescence intensity of endoge-
nous GKAP and Shank1 was determined from dendritic segments
totaling at least 100–150 mm per cell. Randomly selected dendritic
segments were carefully traced, and the integrated intensity and
area were determined for each segment. The average intensity was
then determined for each cell, and normalized to control
transfected cells (b-gal plus either empty FLAG vector or
pSUPER). Spine measurements were determined from 3–5
dendritic segments per cell, as previously described [25].
Acquisition and quantification of images were performed under
‘‘blinded’’ conditions. Statistical analysis was performed with t-test,
defining n as the number of transfected neurons per condition.
Supporting Information
Figure S1 Specific knockdown of TRIM3 by RNA interference.
(A) Specificity of TRIM3 antibody. COS-7 cells were transfected
with plasmids expressing either TRIM3, TRIM2 or TRIM9, each
tagged at the amino terminus with the FLAG epitope. Cell lysates
were blotted with anti- FLAG and TRIM3 antibodies. (B)
Hippocampal neurons were cotransfected with beta-galactosidase
and either pSUPER or RNAi constructs targeting TRIM3,
TRIM2, the unrelated protein ZnT3 at DIV14. After three days,
cells were briefly fixed with paraformaldehyde followed by
methanol, and then immunostained for beta-galactosidase (red)
and endogenous TRIM3 (green). As an additional control, a neuron
cotransfected with wildtype TRIM3 and the TRIM3/2756 RNAi
construct is shown, rescuing knockdown of the endogenous protein.
Under these conditions, beta-galactosidase staining does not
accurately reflect cell morphology. (C) COS-7 cells were triply
transfected with RNAi plasmids targeting either TRIM3 or the
related gene TRIM2, cDNAs expressing TRIM3 (upper panel) or
TRIM2 (lower panel) under the control of a doxycycline-inducible
promoter, and a plasmid encoding a doxycycline-dependent
transcriptional activator. After treatmentwith doxycyclineto induce
the TRIM transcription, cells were lysed and immunoblotted with
FLAG antibody to detect the transfected TRIM protein.
Found at: doi:10.1371/journal.pone.0009842.s001 (1.88 MB TIF)
Figure S2 Expression of TRIM3 in cultured hippocampal
neurons in response to changes in activity. (A) DIV17 hippocam-
pal neurons were treated with either bicuculline (50 micromolar)
or TTX (3 micromolar) for the indicated times. Total cell lysates
were immunoblotted for TRIM3. (B) Hippocampal neurons were
treated with either bicuculline or TTX for 24 hr. There is no
change in TRIM3 expression or localization. In contrast, GKAP
and PSD-95 expression is downregulated by bicuculline and
upregulated by TTX.
Found at: doi:10.1371/journal.pone.0009842.s002 (0.87 MB TIF)
Figure S3 Effect of TRIM3 perturbation on dendritic spine
length. (A) Quantification of dendritic spine lengths from cultured
hippocampal neurons cotransfected with beta-galactosidase and
either empty FLAG vector (Control), FLAG-TRIM3 (wildtype), or
TRIM3 mutants defective in RING finger function (Delta-RING
or C22S/C25S) (representative cells shown in Figure 5A). (B)
Effect of TRIM3 knockdown by RNAi on dendritic spine length
(representative cells shown in Figure 5C). Bar graphs show mean
+/2 SEM. Cumulative frequency distributions are shown at right.
Found at: doi:10.1371/journal.pone.0009842.s003 (0.38 MB TIF)
Table S1 RNAi targeting sequences used in this study.
Found at: doi:10.1371/journal.pone.0009842.s004 (0.05 MB
DOC)
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